Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng-Chun Hung

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Frontiers in Nutrition|July 14, 2026
Geriatric nutritional risk index as a prognostic marker for patients with advanced or metastatic urothelial carcinoma receiving immune checkpoint inhibitorsLi-Wen Chang, Chia-Yen Lin, Cheng-Che Chen, et al.
Anticancer Research|February 28, 2023
First-line Chemotherapy Response Is Associated With Clinical Outcome During Immune Checkpoint Inhibitor Treatment in Advanced Urothelial Carcinoma: A Real World Retrospective StudyJian-Ri Li, Shian-Shiang Wang, Kevin Lu, et al.
Urologic Oncology|May 3, 2021
The effect of metastasectomy on overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysisPo-Yen Hsieh, Sheng-Chun Hung, Jian-Ri Li, et al.
Anticancer Research|March 29, 2022
Tumor Size Significantly Affects Prognosis in Pathological T3a Renal Cell CarcinomaGu-Shun Lai, Jian-Ri Li, Shian-Shiang Wang, et al.
Anticancer Research|April 5, 2017
Comparison of Efficacy of Adjuvant MEC (Methotrexate, Epirubicin and Cisplatin) and GC (Gemcitabine and Cisplatin) in Advanced Upper Tract Urothelial CarcinomaSheng-Chun Hung, Shian-Shiang Wang, Chun-Kuang Yang, et al.
In Vivo (Athens, Greece)|February 24, 2021
Prognostic Evaluation of the Site of Invasion in Pathological Stage T3a Renal Cell CarcinomaGu-Shun Lai, Jian-Ri Li, Shian-Shiang Wang, et al.
Scientific Reports|November 18, 2024
Enhancing screening rates for bone health management in prostate cancer patients on androgen deprivation therapy with an automated outpatient systemChun-Li Wang, Shian-Shiang Wang, Chuan-Shu Chen, et al.
Frontiers in Pharmacology|April 10, 2024
Cost-effectiveness of immune checkpoint inhibitors in treating metastatic urothelial cancerLi-Yu Yang, Jian-Ri Li, Chuan-Shu Chen, et al.
Plos One|March 28, 2024
Outcome benefits of upfront cytoreductive nephrectomy for patients with metastatic renal cell carcinoma: An analysis of the TriNetX databaseGu-Shun Lai, Jian-Ri Li, Shian-Shiang Wang, et al.
In Vivo (Athens, Greece)|March 1, 2020
Survival Analysis of Pathological T3a Upstaging in Clinical T1 Renal Cell CarcinomaGu-Shun Lai, Jian-Ri Li, Shian-Shiang Wang, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Frontiers in Nutrition|July 14, 2026
Geriatric nutritional risk index as a prognostic marker for patients with advanced or metastatic urothelial carcinoma receiving immune checkpoint inhibitorsLi-Wen Chang, Chia-Yen Lin, Cheng-Che Chen, et al.
Anticancer Research|February 28, 2023
First-line Chemotherapy Response Is Associated With Clinical Outcome During Immune Checkpoint Inhibitor Treatment in Advanced Urothelial Carcinoma: A Real World Retrospective StudyJian-Ri Li, Shian-Shiang Wang, Kevin Lu, et al.
Urologic Oncology|May 3, 2021
The effect of metastasectomy on overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysisPo-Yen Hsieh, Sheng-Chun Hung, Jian-Ri Li, et al.
Anticancer Research|March 29, 2022
Tumor Size Significantly Affects Prognosis in Pathological T3a Renal Cell CarcinomaGu-Shun Lai, Jian-Ri Li, Shian-Shiang Wang, et al.
Anticancer Research|April 5, 2017
Comparison of Efficacy of Adjuvant MEC (Methotrexate, Epirubicin and Cisplatin) and GC (Gemcitabine and Cisplatin) in Advanced Upper Tract Urothelial CarcinomaSheng-Chun Hung, Shian-Shiang Wang, Chun-Kuang Yang, et al.
In Vivo (Athens, Greece)|February 24, 2021
Prognostic Evaluation of the Site of Invasion in Pathological Stage T3a Renal Cell CarcinomaGu-Shun Lai, Jian-Ri Li, Shian-Shiang Wang, et al.
Scientific Reports|November 18, 2024
Enhancing screening rates for bone health management in prostate cancer patients on androgen deprivation therapy with an automated outpatient systemChun-Li Wang, Shian-Shiang Wang, Chuan-Shu Chen, et al.
Frontiers in Pharmacology|April 10, 2024
Cost-effectiveness of immune checkpoint inhibitors in treating metastatic urothelial cancerLi-Yu Yang, Jian-Ri Li, Chuan-Shu Chen, et al.
Plos One|March 28, 2024
Outcome benefits of upfront cytoreductive nephrectomy for patients with metastatic renal cell carcinoma: An analysis of the TriNetX databaseGu-Shun Lai, Jian-Ri Li, Shian-Shiang Wang, et al.
In Vivo (Athens, Greece)|March 1, 2020
Survival Analysis of Pathological T3a Upstaging in Clinical T1 Renal Cell CarcinomaGu-Shun Lai, Jian-Ri Li, Shian-Shiang Wang, et al.
Pageof 8